Coloplast A/S

Common Name

Coloplast

Country

Denmark

Sector

Healthcare

Industry

Medical Instruments & Supplies

Employees

16,814

Ticker

COLO B

Exchange

NASDAQ COPENHAGEN A/S

Website

www.coloplast.dk

Description

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates thro... Show more

Financial Statements of Coloplast

Below are the financial statements of Coloplast, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of DKK	2024	2023
Intangible assets	30,332^a	31,255^a
Property, plant and equipment	5,649^a	5,131^a
Right-of-use assets	922^a	848^a
Other equity investments	74^a	65^a
Deferred tax asset	624^a	884^a
Other receivables	28^a	39^a
Non-current assets	37,629^a	38,222^a
Inventories	3,672^a	3,522^a
Trade receivables	4,675^a	4,315^a
Income tax	509^a	532^a
Other receivables	366^a	273^a
Prepayments	434^a	384^a
Cash and cash equivalents	788^a	911^a
Current assets	10,444^a	9,937^a
Assets	48,073^a	48,159^a
Share capital	228^a	228^a
Currency translation reserve	-1,837^a	-1,579^a
Reserve for hedging	329^a	423^a
Proposed ordinary dividend for the year	3,831^a	3,595^a
Retained earnings	15,391^a	14,632^a
Equity	17,942^a	17,299^a
Provisions for pensions and similar liabilities	126^a	124^a
Deferred tax liability	2,481^a	2,122^a
Other provisions	21^a	71^a
Bonds	11,557^a	11,558^a
Other credit institutions	5,000^a	0^a
Other payables	1^a	4^a
Lease liability	734^a	664^a
Prepayments	7^a	6^a
Non-current liabilities	19,927^a	14,549^a
Provisions for pensions and similar liabilities	7^a	7^a
Other provisions	48^a	186^a
Bonds	0^a	4,847^a
Other credit institutions	5,085^a	2,268^a
Trade payables	1,519^a	1,294^a
Income tax	866^a	4,229^a
Other payables	2,425^a	3,249^a
Lease liability	253^a	230^a
Prepayments	1^a	1^a
Current liabilities	10,204^a	16,311^a
Equity and liabilities	48,073^a	48,159^a

Verified Sources Behind Coloplast’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Coloplast’s data sources below and access millions more through our Disclosure Search.

a. Coloplast's Annual Report 2024

Trace every data point back to Coloplast’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Coloplast A/S

Financial Statements of Coloplast

Verified Sources Behind Coloplast’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Genmab A/S

Ascendis Pharma A/S

H Lundbeck A/S

Ambu A/S

Demant A/S

Novo Nordisk A/S